Clinical Trials Browser

Completed × Carcinoma, Transitional Cell × Trastuzumab × Clear all

NCT01828736 2017-02-06

CVH-CT02

Phase 2 Completed

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell